News
1/4/2016

IMIM: Hospital del Mar and Vall d'Hebron take part in the biggest international genomic study into strokes

IMIM: Hospital del Mar and Vall d'Hebron take part in the biggest international genomic study into strokes


News from IMIM


The Hospital del Mar Medical Research Institute and the Vall d'Hebron Research Institute, in collaboration with the MútuaTerrassa Foundation, were the only Spanish research centres to participate in the largest study to date into genome association with ischaemic stroke, and which involved around 38,000 patients and 400,000 control subjects. The study, published recently in Lancet Neurology by two international consortia, has led to the identification of a gene implicated in atherothrombotic ischaemic stroke. The team of Dr. Jordi Jiménez-Conde, head of the Genetics Area within the Neurovascular Research Group at the IMIM and a neurologist at the Hospital del Mar, took part in the discovery phase of the study. The researchers were able to detect genetic variants of the gene TSPAN2, associated with the risk of atherothrombotic stroke. This gene is expressed in blood vessels and blood, and up to this point had only been seen to have a genetic association with migraine.

More information:
IMIM Website